This was a presentation for a London Drugs Policy Forum seminar on e cigarettes, on why e cigarettes are an important part of a tobacco control strategy
This was a presentation for the E cigarette summit 2015 on challenges for local public health systems
The presentations and agenda will all be uploaded here http://www.e-cigarette-summit.com/
Applying behavioural insights to public policyMetroWater
Behavioural insights draws on research into behavioural economics and psychology to influence choices
in decision-making. By focusing on the social,
cognitive and emotional behaviour of individuals
and institutions it suggests that subtle changes to the way in which decisions are framed and conveyed can have big impacts on behaviour.
The NSW Government is now among the world leaders in the application of behavioural insights to public policy with a dedicated central team and work program within the Department of Premier and Cabinet. The Behavioural Insights Unit will discuss how behavioural insights is being applied to innovative policy making and trials underway in NSW and overseas and shows how it can be applied in the water and sustainability spheres.
Circles of San Antonio Community Coalition Staff conducted a presentation for the Prevention Resource Center, Region 8 on why Alcohol is the # 1 drug of concern in San Antonio and Texas.
This was a presentation for a London Drugs Policy Forum seminar on e cigarettes, on why e cigarettes are an important part of a tobacco control strategy
This was a presentation for the E cigarette summit 2015 on challenges for local public health systems
The presentations and agenda will all be uploaded here http://www.e-cigarette-summit.com/
Applying behavioural insights to public policyMetroWater
Behavioural insights draws on research into behavioural economics and psychology to influence choices
in decision-making. By focusing on the social,
cognitive and emotional behaviour of individuals
and institutions it suggests that subtle changes to the way in which decisions are framed and conveyed can have big impacts on behaviour.
The NSW Government is now among the world leaders in the application of behavioural insights to public policy with a dedicated central team and work program within the Department of Premier and Cabinet. The Behavioural Insights Unit will discuss how behavioural insights is being applied to innovative policy making and trials underway in NSW and overseas and shows how it can be applied in the water and sustainability spheres.
Circles of San Antonio Community Coalition Staff conducted a presentation for the Prevention Resource Center, Region 8 on why Alcohol is the # 1 drug of concern in San Antonio and Texas.
This presentation was given to the national Public Health Stakeholder Forum for England on 21 January 2015. It covers my take on tobacco control priorities and work we need to do
"Mirror, mirror on the wall..." - the grooming habits of UK men and womenHarris Interactive UK
An Omnibus study by Harris Interactive's consumer research team into the grooming habits of UK men and women. Conducted online amongst a nationally representative sample of 2,061 GB adults.
- 14% of all men regularly use female grooming products
- 63% of men brush their teeth twice a day compared to 74% of women
- 19% of women feel their male partner spends longer than they do getting ready.
Redefining Relationships between Citizens, Communities and Services and Diffe...Mentor
Our new Chief Executive Michael O'Toole made a presentation at the Capita Conference 'Managing Demand in Public Services' held in London on 21st October 2014.
[Webinar] Support disabled job seekers on their journey into workPolicy in Practice
View the slidedeck from this webinar to learn how frontline advisors are helping people who have a disability, and who are seeking work, to understand benefit changes as Universal Credit changes roll out. With Marise Mackie, Pluss.
Local organisations play an important role in ensuring people with disability and illness receive the correct benefit support, whether they're working, unable to work or considering a return to work.
Supporting people with disability and illness is made more complicated by the types of benefit available under both legacy benefits and Universal Credit.
The roll out of Universal Credit means there is more pressure on support organisations to make sure their customers are prepared for the likely changes.
Many organisations working with people with disability or illness use Policy in Practice's Benefit and Budgeting Calculator to help their customers understand the benefits they could get, and the impact of earnings or other changes of circumstances.
In this webinar guest speaker, Marise Mackie from Pluss, shared how they support customers as the Work and Health Programme gets underway.
Listen back to learn about:
- the impact of Universal Credit on household income for those living with a disability or illness
- information needed for people to make decisions, under legacy benefits and Universal Credit
- support tools that can help ensure accurate, client-focused, information is given to those who need it
For more information please:
visit www.policyinpractice.co.uk
call 0330 088 9242
email hello@policyinpractice.co.uk
Employment and Skills 2018: Universal Credit and Work and Health: Practical e...Policy in Practice
Policy in Practice was invited to host a session on how Universal Credit is supporting people on the work and health programme at the revamped Employment and Skills Conference 2018.
Policy in Practice’s Benefit and Budgeting Calculator helps people on the Work and Health programme understand and navigate the benefit system and how the move onto Universal Credit will affect them. In our session we were joined by Marise Mackie, Contract Manager, from Pluss and Hazel Dales, Partnership & Integration Manager from Ingeus. They shared practical, on the ground examples of the work they’re doing to help people transform their lives as Universal Credit rolls out across the UK.
To find out how Policy in Practice’s software helps build financial resilience visit www.policyinpractice.co.uk/software, email hello@policyinpractice.co.uk or call 0330 088 9242.
Using benefits data to study employment trends in London Policy in Practice
Deven Ghelani, Director and Founder of Policy in Practice, delivered this presentation at the ERSA Employment Support London meeting on 22 February 2018.
In it he answers three questions employment related questions using findings from recent analysis on low income Londoners carried out by Policy in Practice, funded by Trust for London.
The questions were:
1. What are the biggest barriers to work in London?
2. What impact are welfare reforms having on employment outcomes?
3. Self employment is a popular choice in London; how will Universal Credit impact this group?
For more information about Policy in Practice's work please email hello@policyinpractice.co.uk.
This is my presentation to the Hertfordshire Tobacco Control Alliance Conference for 21st January 2016. It's intended to be a think piece, a look at strategic challenges facing tobacco control and smoking cessation, and examine whether and how ecigarettes can be a help in addressing them
This presentation was given to the national Public Health Stakeholder Forum for England on 21 January 2015. It covers my take on tobacco control priorities and work we need to do
"Mirror, mirror on the wall..." - the grooming habits of UK men and womenHarris Interactive UK
An Omnibus study by Harris Interactive's consumer research team into the grooming habits of UK men and women. Conducted online amongst a nationally representative sample of 2,061 GB adults.
- 14% of all men regularly use female grooming products
- 63% of men brush their teeth twice a day compared to 74% of women
- 19% of women feel their male partner spends longer than they do getting ready.
Redefining Relationships between Citizens, Communities and Services and Diffe...Mentor
Our new Chief Executive Michael O'Toole made a presentation at the Capita Conference 'Managing Demand in Public Services' held in London on 21st October 2014.
[Webinar] Support disabled job seekers on their journey into workPolicy in Practice
View the slidedeck from this webinar to learn how frontline advisors are helping people who have a disability, and who are seeking work, to understand benefit changes as Universal Credit changes roll out. With Marise Mackie, Pluss.
Local organisations play an important role in ensuring people with disability and illness receive the correct benefit support, whether they're working, unable to work or considering a return to work.
Supporting people with disability and illness is made more complicated by the types of benefit available under both legacy benefits and Universal Credit.
The roll out of Universal Credit means there is more pressure on support organisations to make sure their customers are prepared for the likely changes.
Many organisations working with people with disability or illness use Policy in Practice's Benefit and Budgeting Calculator to help their customers understand the benefits they could get, and the impact of earnings or other changes of circumstances.
In this webinar guest speaker, Marise Mackie from Pluss, shared how they support customers as the Work and Health Programme gets underway.
Listen back to learn about:
- the impact of Universal Credit on household income for those living with a disability or illness
- information needed for people to make decisions, under legacy benefits and Universal Credit
- support tools that can help ensure accurate, client-focused, information is given to those who need it
For more information please:
visit www.policyinpractice.co.uk
call 0330 088 9242
email hello@policyinpractice.co.uk
Employment and Skills 2018: Universal Credit and Work and Health: Practical e...Policy in Practice
Policy in Practice was invited to host a session on how Universal Credit is supporting people on the work and health programme at the revamped Employment and Skills Conference 2018.
Policy in Practice’s Benefit and Budgeting Calculator helps people on the Work and Health programme understand and navigate the benefit system and how the move onto Universal Credit will affect them. In our session we were joined by Marise Mackie, Contract Manager, from Pluss and Hazel Dales, Partnership & Integration Manager from Ingeus. They shared practical, on the ground examples of the work they’re doing to help people transform their lives as Universal Credit rolls out across the UK.
To find out how Policy in Practice’s software helps build financial resilience visit www.policyinpractice.co.uk/software, email hello@policyinpractice.co.uk or call 0330 088 9242.
Using benefits data to study employment trends in London Policy in Practice
Deven Ghelani, Director and Founder of Policy in Practice, delivered this presentation at the ERSA Employment Support London meeting on 22 February 2018.
In it he answers three questions employment related questions using findings from recent analysis on low income Londoners carried out by Policy in Practice, funded by Trust for London.
The questions were:
1. What are the biggest barriers to work in London?
2. What impact are welfare reforms having on employment outcomes?
3. Self employment is a popular choice in London; how will Universal Credit impact this group?
For more information about Policy in Practice's work please email hello@policyinpractice.co.uk.
This is my presentation to the Hertfordshire Tobacco Control Alliance Conference for 21st January 2016. It's intended to be a think piece, a look at strategic challenges facing tobacco control and smoking cessation, and examine whether and how ecigarettes can be a help in addressing them
This lecture is about quitting smoking or smoking cessation. Lighting a cigarette and inhaling the smoke is bad for the health. Healthy lifestyle including a very good diet, regular exercises, enough sleep and a less stressful life is very important.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Hazel Cheeseman & Ian Gray - E-Cigarette Summit 2014
1. Hazel Cheeseman
Director of Policy
Action on Smoking and Health
Ian Gray, CFCIEH, MBE
Chief Policy Officer, Chartered Institute of Environmental Health
2. Permitting or prohibiting vaping – ingredients for developing a policy
Ian Gray
Principal Policy Office
Chartered Institute of Environmental Health
Hazel Cheeseman
Director of Policy
Action on Smoking and Health
3. The project
•Support small number of councils through policy development process
•Learn from their experiences to share ideas about a good process with others
•To date worked with seven councils, three now have formal policies, rest in development
•Next year we’ll publish conclusions
•This presentation is based on lesson’s we’ve learnt working with these councils and others around the UK.
3
4. Why do organisations find this difficult issue to address?
•Complexities
•Confusion
•Conflicting beliefs
4
5. Complexities: There are no easy answers
“Are they safe to use?”
“Will they lead to more children smoking?”
“Will they undermine smokefree legislation?”
“Will banning them have a negative effect on people trying to quit?”
5
“They’re safer than smoking”
“There’s no evidence of this yet…”
“They haven’t yet, we don’t think they will…”
“We don’t know, it’s possible…”
6. Complexities: competing ‘rights’
Number of different and conflicting rights
•Non-smokers and non-vapers to clean air
•Smokers to have alternatives available to them
•Vapers to use a product which does not harm others
•Non-smokers right to ‘smoke’ breaks
•Those trying to quit to use product of choice
•Those trying to quit not to have to stand with smokers
•Those trying to quit who don’t want to see products that look like a cigarette
•Etc etc
6
7. Complexities: a balance of responsibilities
Number of different and conflicting responsibilities
•Promote public health
•Duty of care to staff
•Duty of care to clients and public
•Support smokers to quit or reduce harm
•Protect corporate image
•Minimise workplace conflict
•Maximise the choice of vulnerable service users
•Locus Parentis
•Etc etc
7
8. Confusion: failure to distinguish between smoke and vapour
8
0%
5%
10%
15%
20%
25%
30%
35%
40%
A LOT MORE
harmful
MORE
harmful
JUST AS
harmful
LESS harmful
A LOT LESS
harmful
Completely
harmless
Don’t know
Do you think electronic cigarettes are more, less or as harmful as regular cigarettes?
9. Confusion: poor knowledge of nicotine
9
0%
5%
10%
15%
20%
25%
None or very
small
Some but
well under
half the risk
Around half
the risk
Much more
than half the
risk
Nearly all
the risk
Don’t know
According to what you know or believe, what portion of the health risks of smoking comes from nicotine in cigarettes?
10. Conflicting beliefs: addiction
“harm reduction will leave people addicted to nicotine forever..”
“Its wrong not to support people on low incomes to overcome their addictions…”
“Smokers don’t need nicotine, they should just go cold turkey…”
10
“I’ve got a right to my addiction if it doesn’t bother anyone else”
“What’s the difference between your coffee addiction and my electronic cigarette addiction?”
“People are more likely to quit and stay quit with support and access to nicotine”
11. Conflicting beliefs: tobacco industry
“If the tobacco industry is involved then it must be for the wrong reasons – we must have nothing to do with this agenda”
11
“Our policies on nicotine containing products should be developed in the interests of the public’s health regardless of who develops or markets them.”
12. Why do organisations find this difficult issue to address?
•Complexities – people (and corporate policies) struggle to manage complexity
•Confusion – without a shared understanding of some basic evidence development of good policy is a challenge
•Conflicting beliefs – slow and difficult to find consensus on questions of belief
12
13. The spectrum of permissiveness
Complete prohibition
Qualified use
Complete freedom
13
14. Ingredients needed for policy development
1.Identify key principles and policy objectives
•Vaping and smoking are not the same
•NICE guidance directs us to reduce harm from tobacco use
•Policies should aim to maximise public health gain
2.The right stakeholders engaged
3.The best evidence considered
4.Using appropriate language
5.Review fit with existing policies and strategies
6.Clear process for implementation and review
14